Found: 372
Select item for more details and to access through your institution.
The JOPT Story: 40 Years of Growth and Focus.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 3, p. 155, doi. 10.1089/jop.2024.29121.editorial
- By:
- Publication type:
- Article
Editor's Letter.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 3, p. 157, doi. 10.1089/jop.2024.29122.ujp
- By:
- Publication type:
- Article
Acknowledgment of Reviewers 2023.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 3, p. 201, doi. 10.1089/jop.2023.29117.ack
- Publication type:
- Article
Editorial: Combating antimicrobial resistance: peptides and other novel therapeutic interventions to treat ocular, oral and skin infections.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1388744
- By:
- Publication type:
- Article
OCTN2- and ATB<sup>0,+</sup>-targeted nanoemulsions for improving ocular drug delivery.
- Published in:
- Journal of Nanobiotechnology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12951-024-02402-x
- By:
- Publication type:
- Article
Eyes on New Product Development.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 10, p. 673, doi. 10.1089/jop.2023.29116.gdn
- By:
- Publication type:
- Article
Editorial: Innovation in ocular pharmacology.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1242014
- By:
- Publication type:
- Article
Regeneration and Vision Restoration.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 8, p. 473, doi. 10.1089/jop.2023.29111.mve
- By:
- Publication type:
- Article
Editor's Letter.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 7, p. 415, doi. 10.1089/jop.2023.29113.editorial
- By:
- Publication type:
- Article
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for the Journal of Ocular Pharmacology and Therapeutics.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 6, p. 361, doi. 10.1089/jop.2023.29107.rfs2022
- By:
- Publication type:
- Article
Correction to: Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes, by Obata et al. J. Ocul. Pharmacol. Ther 2023;39(3):225–228. DOI: 10.1089/jop.2022.0160.
- Published in:
- 2023
- Publication type:
- Correction Notice
The Antiangiogenic Effect and Ocular Pharmacology of Novel Modified Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Oxygen-Induced Retinopathy.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 4, p. 279, doi. 10.1089/jop.2022.0113
- By:
- Publication type:
- Article
Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 4, p. 1094, doi. 10.3390/pharmaceutics15041094
- By:
- Publication type:
- Article
Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology: A Comprehensive Review.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 4, p. 1167, doi. 10.3390/pharmaceutics15041167
- By:
- Publication type:
- Article
Acknowledgment of Reviewers 2021–2022.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 2, p. 185, doi. 10.1089/jop.2022.29099.ack
- Publication type:
- Article
Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.848332
- By:
- Publication type:
- Article
Ocular Drug Delivery Technology Special Issue.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Ocular Drug Delivery Technology Special Issue.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Regulations, Generics, and Disruptive Technologies in Ophthalmology: What Every Scientist Needs to Know.
- Published in:
- 2021
- By:
- Publication type:
- journal article
15th Biennial AOPT Scientific Meeting: Restoring Vision Through Regeneration Virtual Meeting, March 4th-7th, 2021.
- Published in:
- 2020
- By:
- Publication type:
- editorial
Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 7, p. 980, doi. 10.3390/biom10070980
- By:
- Publication type:
- Article
Correction to: Matrix Metalloproteinases and Glaucoma Treatment, by Weinreb, R.N., Robinson, M.R., Dibas, M. and Stamer, W.D. J Ocul Pharmacol Ther 2020;36(4):208-228. DOI: 10.1089/jop.2019.0146.
- Published in:
- 2020
- Publication type:
- corrected article
Correction to: Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells, by Shrestha, A., Allen, B.N., Wiley, L.A. Tucker, B.A., and Worthington, K.S. J Ocul Pharmacol Ther 2020;36(1):42–55. DOI: 10.1089/jop.2018.0146
- Published in:
- 2020
- Publication type:
- corrected article
Next Generation Tissue Engineering: Inspired Models for Ophthalmic Drug Discovery.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: , by Blumenthal, E.Z, Cordeiro, M.F., Schmetterer, L. Verbin, H.L., and Harris, A. J Ocul Pharmacol Ther 2019;35(8):441-446. DOI: 10.1089/jop.2019.0004.
- Published in:
- 2019
- Publication type:
- corrected article
Illicit drugs: Effects on eye.
- Published in:
- Indian Journal of Medical Research, 2019, v. 150, n. 3, p. 228, doi. 10.4103/ijmr.IJMR_1210_17
- By:
- Publication type:
- Article
Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies.
- Published in:
- Clinical Ophthalmology, 2019, v. 13, p. 1439, doi. 10.2147/OPTH.S208700
- By:
- Publication type:
- Article
Tegafur and 5-fluorouracil levels in tears and changes in tear volume in long-term users of the oral anticancer drug S-1.
- Published in:
- Nagoya Journal of Medical Science, 2019, v. 81, n. 3, p. 415, doi. 10.18999/nagjms.81.3.415
- By:
- Publication type:
- Article
Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00752
- By:
- Publication type:
- Article
Lipid Lowering and Incidence of Cataract, a Role for Fibrates.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 318, doi. 10.1002/cpt.1269
- By:
- Publication type:
- Article
Effect of Eyelid Hygiene Detergent on Obstructive Meibomian Gland Dysfunction.
- Published in:
- Journal of Oleo Science, 2019, v. 68, n. 1, p. 67, doi. 10.5650/jos.ess18161
- By:
- Publication type:
- Article
Drug Prescription in Ophthalmology.
- Published in:
- Egyptian Journal of Hospital Medicine, 2017, v. 69, n. 7, p. 2856, doi. 10.12816/0042578
- By:
- Publication type:
- Article
In Silico Ocular Pharmacokinetic Modeling: Delivery of Topical FK962 to Retina.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Stability Indicating UHPLC-PDA Assay for Simultaneous Determination of Antazoline Hydrochloride and Naphazoline Hydrochloride in Ophthalmic Formulations.
- Published in:
- Acta Chimica Slovenica, 2017, v. 64, n. 2, p. 332, doi. 10.17344/acsi.2017.3166
- By:
- Publication type:
- Article
Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dealing with ocular artifacts on lateralized ERPs in studies of visual-spatial attention and memory: ICA correction versus epoch rejection.
- Published in:
- Psychophysiology, 2017, v. 54, n. 1, p. 83, doi. 10.1111/psyp.12675
- By:
- Publication type:
- Article
The use of colour Doppler imaging to determine the effects of administration of butorphanol, medetomidine and ketamine on indices of feline ocular impedance.
- Published in:
- Veterinární Medicína, 2017, v. 62, n. 1, p. 35, doi. 10.17221/77/2016-VETMED
- By:
- Publication type:
- Article
Eyes on New Product Development.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:355-364.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2016, v. 32, n. 10, p. 695, doi. 10.1089/jop.2015.0116.correx
- Publication type:
- Article
Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:606-622.
- Published in:
- 2016
- Publication type:
- journal article
Distributions of Direct, Reflected, and Diffuse Irradiance for Ocular UV Exposure at Different Solar Elevation Angles.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0166729
- By:
- Publication type:
- Article
General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.
- Published in:
- Pharmaceutical Research, 2016, v. 33, n. 11, p. 2680, doi. 10.1007/s11095-016-1993-2
- By:
- Publication type:
- Article
Mathematical assessment of drug build-up in the posterior eye following transscleral delivery.
- Published in:
- Journal of Mathematics in Industry, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13362-016-0031-7
- By:
- Publication type:
- Article
Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Eyes on New Product Development.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Recent Advances in Topical Ocular Drug Delivery.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Nonresponders to Prostaglandin Analogs Among Normal-Tension Glaucoma Patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The In Vitro Evaluation of Tigecycline and the In Vivo Evaluation of RPX-978 (0.5% Tigecycline) as an Ocular Antibiotic.
- Published in:
- 2016
- By:
- Publication type:
- journal article